Patient Leaflet Updated 28-Nov-2024 | Thame Laboratories
Syrisal 1mmol/ml Oral Solution
Syrisal 1mmol/ml Oral Solution
(sodium chloride)
The name of your medicine is Syrisal 1mmol/ml Oral Solution but it will be referred to as Syrisal throughout this leaflet.
1. What Syrisal is and what it is used for
2. What you need to know before you take Syrisal
3. How to take Syrisal
4. Possible side effects
5. How to store Syrisal
6. Contents of the pack and other information
Syrisal contains active substance sodium chloride which is a sodium supplement. Sodium chloride is the chemical name for salt. Sodium is an electrolyte that regulates the amount of water in your body. Sodium also plays a part in transmission of nerve impulses and muscle contractions.
Syrisal is used for the treatment and prevention of sodium chloride deficiency.
Talk to your doctor or pharmacist before taking Syrisal.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines you buy without a prescription, including herbal medicines and dietary supplements. This is because Syrisal can affect the way some other medicines work and some medicines can have an effect on the way Syrisal works.
In particular, tell your doctor if you are taking any of the following:
Syrisal may be taken with or without food.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Syrisal does not affect the ability to drive or operate machinery.
This product contains 1mmol (23mg) sodium per ml. To be taken into consideration by patients on a controlled sodium diet.
This product also contains methyl and propyl parahydroxybenzoate, which may cause allergic reactions (possibly delayed).
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Chronic salt depletion
Adults: 40-80ml (2.4-4.8g) daily accompanied by suitable fluid intake at intervals as directed by your healthcare provider.
Use in Children and adolescents: The healthcare provider will adjust the dose to the individual needs of the child. This medicine can be mixed with breast milk or formula milk for newborn babies.
Kidney Impairment: Dose adjustment may be necessary.
This medicinal product must be taken orally.
Syrisal oral solution may be diluted in a glass of water or baby’s bottle.
Use the measuring syringe provided in the pack to deliver the required dose.
If you take more Syrisal than you should, tell your doctor or go to your nearest hospital casualty department straight away. Take the medicine pack with you. Overdose may result in restlessness, weakness, thirst, dry mouth and eyes, swollen tongue, flushing of the skin, dizziness, headache, decreased production of urine, high blood pressure, fast heart beat, delirium.
If you forget a dose, take it as soon as you remember. However, if it is nearly time for the next dose, skip the missed dose.
Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Seek medical attention immediately if any of these severe side effects occur:
Other side effects include:
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
The active substance is sodium chloride.
Each ml of oral solution contains 1mmol (58.44mg) sodium chloride.
The other ingredients are glycerol (E422), sodium citrate, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216) and purified water.
Syrisal is a clear, colourless solution supplied in an amber glass bottle with a child resistant plastic screw cap with a 20ml oral syringe with 1ml graduation mark for measuring and administering the dose and a syringe adaptor.
Syrisal Oral Solution is supplied in bottles containing 100ml and 300ml oral solution.
Not all pack size may be marketed.
POM
This leaflet was last revised in 05/2020.
If this leaflet is hard to see or read, please telephone +44 (0) 208 515 3700 for help.
PIL/UK/MFG012/06/SMD/v1
Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU
0330 1359 422
+44 (0)208 515 3700
http://www.thamelabs.co.uk
+44 (0)208 515 3700
+44 (0)208 515 3700